GeneDx Corp. (WGS)
undefined
undefined%
At close: undefined
75.43
-0.01%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 202.57M 234.69M 212.19M 179.32M 196.17M
Cost of Revenue 141.94M 261.44M 228.80M 175.30M 113.39M
Gross Profit 60.62M -26.75M -16.60M 4.03M 82.78M
Operating Income -163.66M -667.65M -446.15M -241.99M -30.41M
Interest Income 1.11M 2.54M 79.00K 506.00K 988.00K
Pretax Income -176.69M -598.03M -245.39M -241.34M -29.70M
Net Income -175.77M -548.98M -245.39M -246.44M -30.99M
Selling & General & Admin 194.71M 338.24M 318.73M 163.93M 68.84M
Research & Development 58.27M 86.20M 105.16M 72.70M 34.91M
Other Expenses -28.69M 6.31M 5.66M 9.39M 9.45M
Operating Expenses 224.28M 430.76M 429.55M 246.02M 113.20M
Interest Expense - 3.21M 2.83M 2.47M 783.00K
Selling & Marketing Expenses 60.96M 134.91M 112.74M 63.18M 39.35M
Cost & Expenses 366.23M 692.20M 658.34M 421.32M 226.59M
Income Tax -926.00K -49.05M 21.57M 5.10M 1.29M
Shares Outstanding (Basic) 24.31M 10.24M 3.28M 155.48 7.28M
Shares Outstanding (Diluted) 24.31M 10.24M 3.28M 155.48 7.28M
EPS (Basic) -7.23 -53.63 -74.93 -1.58M -4.26
EPS (Diluted) -7.23 -53.63 -74.93 -1.58M -4.26
EBITDA -136.46M -398.20M -219.19M -224.73M -22.51M
Depreciation & Amortization 33.73M 63.03M 23.36M 14.13M 6.41M